13 commercial payer policies list Q5161. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
13 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab and Biosimilars for Non-Oncologic Indications | Jan 1, 2026 | Covered |
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab and Biosimilars for Non-Oncologic Indications | Jan 1, 2026 | Covered |
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab and Biosimilars for Non-Oncologic Indications | Jan 1, 2026 | Covered |
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab and Biosimilars for Non-Oncologic Indications | Jan 1, 2026 | Covered |
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab | Oct 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab | Oct 1, 2026 | Covered |
| Policy | Effective | Status of Q5161 |
|---|---|---|
| Denosumab | Oct 1, 2026 | Covered |